In 2011, over 75,000 individuals in the United States were diagnosed with lymphoma, a group of cancers originating in the lymphatic system. Non-Hodgkin lymphoma, the seventh most common cancer in the United States, accounts for approximately 88 percent of all lymphoma diagnoses. To help people become more aware of this difficult-to-diagnose cancer, The Leukemia & Lymphoma Society along with Saint Francis University’s CERMUSA and the DiSepio Institute for Rural Health and Wellness is sponsoring “Non-Hodgkin Lymphoma: The Changing Landscape,” a program for patients and caregivers at the Hollidaysburg Area YMCA on Monday, January 28, 2013 at 6:00 PM.
Between 1975 through 2008, non-Hodgkin lymphoma incidence rates have risen 82.5 percent, or nearly 2.4 percent per year. This educational symposium will address the needs of patients and their families and help them better understand the disease and how to treat it.
While the exact cause of non-Hodgkin lymphoma remains unknown, research has focused on several possible factors that may contribute to the development of lymphoma including genetic factors, autoimmune disorders, viruses such as HIV/AIDS and exposure to carcinogens, such as herbicides or pesticides.
The most common early symptom of non-Hodgkin lymphoma is painless enlargement of one or more lymph nodes. Other symptoms may include recurrent high fever, persistent cough and shortness of breath, drenching night sweats of the whole body, itching and weight loss. Some individuals may have no symptoms, and a diagnosis of NHL is made as a result of a periodic physical examination and testing.
The “Non-Hodgkin Lymphoma: The Changing Landscape” program is free, although advance registration is required. Parking and a complimentary dinner buffet will be provided. To register, contact The Leukemia & Lymphoma Society at 1-800-726-2873, ext. 2882 or 412-395-2882.
About The Leukemia & Lymphoma Society
The Leukemia & Lymphoma Society, based in White Plains, NY, is the world's largest voluntary health organization dedicated to blood cancer research, education and patient services. The Society's mission is to cure leukemia, lymphoma, Hodgkin’s disease and myeloma, and improve the quality of life of patients and their families. Since its inception in 1949, LLS has invested more than $814 million in research to find cures and better therapies. For additional information, contact the Society at 1-800-726-2873.